The FDA approved Boston Scientific’s Spectra WaveWriter Spinal Cord Stimulator System. 1. The system is the first and only FDA-approved system that simultaneously provides paresthesia-based and ...
Medical Device Network on MSN
Boston Scientific touts long-term data of SCS therapy
At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
Boston Scientific has received the CE Mark for the Precision Plus Spinal Cord Stimulator System, a rechargeable SCS device. The system provides peripheral nerve stimulation for patients with chronic ...
At least 116 million US adults suffer from chronic pain at a annual cost of $560 to $635 billion in direct medical treatment costs and lost productivity, according to the Institute of Medicine (US) ...
Please provide your email address to receive an email when new articles are posted on . Patients implanted with a spinal cord simulation system reported less severe pain from baseline to follow up.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results